Quote:
Originally Posted by haertig
These specialized clinics would seem the ideal place to distribute vaccinations to the affected individuals, as long as there are enough qualifying patients available to make the difficult storage of Pfizer and Moderna feasible. I hope they are doing that at these clinics. The Johnson & Johnson vaccine may really change the landscape in regards to this however, with it's less stringent storage requirements. J&J may well open up lots of previously non-feasible locations to become distribution centers. I would support setting aside J&J vaccine to service people in special situations where it's storage benefits would really shine, and reserve Pfizer and Moderna for others who are more mobile, have fewer pre-existing conditions, etc. It seems that we have a natural division of vaccine recipients as well as a natural division of vaccines. That split was not intentionally created, but we should take advantage of it none-the-less.
|
(Talking about Ontario, Canada)
They are actually used for the vaccination process (our province finally delivered a really well precise and clear document about it last Friday), they are assigned Pfizer/Moderna stock to High risk people as they have the best clinical protection.
It's also to the benefit of the province to use these resources, as it concerns up to 2.9M identifiable people here in Ontario.
That frees some places to vaccinate people between 60 to 80 in parallel in the regular vaccination spots they designated / created.